InhaleRx (IRX) Stock Price, News & Analysis

Company Overview

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$4.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:IRX
• CIK: N/A
• Web: inhalerx.com.au
• Phone: 61 2 8072 1400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$1.44 million
• Net Margins: -86.39%
• Pretax Margin: N/A
• Return on Equity: -196.76%
• Return on Assets: -51.49%

Debt

• Debt-to-Equity Ratio: -612.89
• Current Ratio: 0.92
• Quick Ratio: 5.69

Sales & Book Value

• Annual Sales: A$1.20 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 193,210,000
• Free Float: N/A
• Market Cap: A$4.70 million
• Optionable: Not Optionable
• Beta: -0.70